Study finds almost 1 in 3 large clinical trials still not published 5 years after completion
Almost one in three (29%) large clinical trials remain unpublished five years after completion. And of these, 78% have no results publicly available, finds a study published on bmj.com today.
This means that an estimated 250,000 people have been exposed to the risks of trial participation without the societal benefits that accompany the dissemination of their results, say the authors.
They argue that this “violates an ethical obligation that investigators have towards study participants” and call for additional safeguards “to ensure timely public dissemination of trial data.”
Randomized clinical trials are a critical means of advancing medical knowledge. They depend on the willingness of people to expose themselves to risks, but the ethical justification for these risks is that society will eventually benefit from the knowledge gained from the trial.
But when trial data remain unpublished, the societal benefit that may have motivated someone to enrol in a study remains unrealized.
US law requires that many trials involving human participants be registered – and their results posted – on the largest clinical trial website ClinicalTrials.gov. But evidence suggests that this legislation has been largely ignored.
So a team of US-based researchers set out to estimate the frequency of non-publication of trial results and, among unpublished studies, the frequency with which results are unavailable in the ClinicalTrials.gov database.
They searched scientific literature databases and identified 585 trials with at least 500 participants that were registered with ClinicalTrials.gov and completed prior to January 2009. The average time between study completion and the final literature search (November 2012) was 60 months for unpublished trials.
Registry entries for unpublished trials were then reviewed to determine whether results for these studies were available in the ClinicalTrials.gov results database.
Of 585 registered trials, 171 (29%) remained unpublished. Of these, 133 (78%) had no results available in ClinicalTrials.gov. Non-publication was more common among trials that received industry funding (32%) than those that did not (18%).
“Our results add to existing work by showing that non-publication is an important problem even among large randomized trials,” say the authors. Furthermore, the sponsors and investigators of these unpublished trials infrequently utilize the ClinicalTrials.gov results database.
Go deeper with Bing News on:
Clinical trials
- India Emerges as a Prime Destination for Clinical Trials: Pharma Industry Leaders
You dont have to run a phase four study if you have a large enough subpopulation from India to contribute to your phase three data, Corsico said, adding that the infrastructure has improved.Dr. Uli ...
- ICMR Expands Clinical Trial Network to Facilitate Comprehensive Healthcare Solutions
ICMR's Indian Clinical Trial and Education Network (INTENT) is expanding by inviting medical research institutes to coordinate regulatory clinical trials for drugs and devices. The network aims to ...
- Getting Blacks into Heart-Related Clinical Trials Isn’t a “Spectator Sport”
Innovative, multilevel strategies focused on Black communities can increase enrollment of this population into clinical research.
- Clinical trial evaluates azithromycin for preventing chronic lung disease in premature babies
The early use of azithromycin does not prevent the development of chronic lung disease in premature babies, finds new research by Cardiff University.
- Experimental NIH Antibody Protects Children From Malaria in Clinical Trial
A new study reports a single dose of a malaria antibody was 77% effective in protecting children in Mali from malaria, marking a significant step in malaria prevention efforts. One injected dose of an ...
Go deeper with Google Headlines on:
Clinical trials
[google_news title=”” keyword=”clinical trials” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Unpublished trial data
- New tool enhances P and K management
FRST provides phosphorus and potassium soil-test values, indicating where there is no expected yield increase from P or K.
- RVPH: Full Year 2023 Results
RVPH READ THE FULL RVPH RESEARCH REPORT 2023 Financial and Operational Results On April 15th, 2024, Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported full-year 2023 financial and operational ...
- Fertilizer Recommendation Support Tool to digitize crop nutrient management
A nationwide team of agricultural scientists, including researchers at Penn State, has launched a decision aid that provides an unbiased, science-based interpretation of soil test phosphorus and potas ...
- Eli Lilly weight loss drug shows promise treating sleep apnea, long linked to obesity
The results, while unpublished, are the latest in a string of hopeful signs for weight loss drugs to treat a variety of conditions.
- 10 Best Sites to Find Out Who Called Me From This Phone Number
The best way to find out who called you from a phone number is to use a reverse phone lookup service such as TruthFinder, Intelius, Instant Checkmate, Spokeo, or BeenVerified.
Go deeper with Google Headlines on:
Unpublished trial data
[google_news title=”” keyword=”Unpublished trial data” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]